Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Melzer

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Today'S FDA : Official Monthly Journal of the Florida Dental Association|February 23, 2013
A call to armsDaniel Melzer
Materials (Basel, Switzerland)|September 28, 2024
Influence of Zinc Chloride Exposure on Microstructure and Mechanical Behavior of Age-Hardened AZ91 Magnesium AlloyPavel Konopík, Tomasz Bucki, Sylwia Rzepa, et al.
Nature Communications|September 7, 2019
Design and synthesis of highly active MoVTeNb-oxides for ethane oxidative dehydrogenationDaniel Melzer, Gerhard Mestl, Klaus Wanninger, et al.
Angewandte Chemie (International Ed. in English)|March 19, 2016
Atomic-Scale Determination of Active Facets on the MoVTeNb Oxide M1 Phase and Their Intrinsic Catalytic Activity for Ethane Oxidative DehydrogenationDaniel Melzer, Pinghong Xu, Daniela Hartmann, et al.
Materials (Basel, Switzerland)|March 11, 2023
Effect of Double-Step and Strain-Assisted Tempering on Properties of Medium-Carbon SteelPavel Salvetr, Andrea Školáková, Jakub Kotous, et al.
Materials (Basel, Switzerland)|February 15, 2022
Prediction of Behaviour of Thin-Walled DED-Processed Structure: Experimental-Numerical ApproachMiroslav Urbánek, Josef Hodek, Daniel Melzer, et al.
Journal of the American Chemical Society|August 22, 2017
Formation of Oxygen Radical Sites on MoVNbTeOx by Cooperative Electron RedistributionYuanyuan Zhu, Peter V Sushko, Daniel Melzer, et al.
Journal of Thoracic Disease|December 13, 2023
Osimertinib <i>vs.</i> afatinib as first-line treatment for patients with metastatic non-small cell lung cancer with an <i>EGFR</i> exon 19 deletion or exon 21 L858R mutationSophia Gilardone, Ram Thapa, José Laborde, et al.
Clinical Lung Cancer|January 16, 2026
Optimizing Tarlatamab Delivery in Small Cell and Neuroendocrine Lung Cancer: Real-World Insights into Step-Up Dosing and Prophylactic Tocilizumab UseUtsav Joshi, Faustine Ong, Daniel Melzer, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Today'S FDA : Official Monthly Journal of the Florida Dental Association|February 23, 2013
A call to armsDaniel Melzer
Materials (Basel, Switzerland)|September 28, 2024
Influence of Zinc Chloride Exposure on Microstructure and Mechanical Behavior of Age-Hardened AZ91 Magnesium AlloyPavel Konopík, Tomasz Bucki, Sylwia Rzepa, et al.
Nature Communications|September 7, 2019
Design and synthesis of highly active MoVTeNb-oxides for ethane oxidative dehydrogenationDaniel Melzer, Gerhard Mestl, Klaus Wanninger, et al.
Angewandte Chemie (International Ed. in English)|March 19, 2016
Atomic-Scale Determination of Active Facets on the MoVTeNb Oxide M1 Phase and Their Intrinsic Catalytic Activity for Ethane Oxidative DehydrogenationDaniel Melzer, Pinghong Xu, Daniela Hartmann, et al.
Materials (Basel, Switzerland)|March 11, 2023
Effect of Double-Step and Strain-Assisted Tempering on Properties of Medium-Carbon SteelPavel Salvetr, Andrea Školáková, Jakub Kotous, et al.
Materials (Basel, Switzerland)|February 15, 2022
Prediction of Behaviour of Thin-Walled DED-Processed Structure: Experimental-Numerical ApproachMiroslav Urbánek, Josef Hodek, Daniel Melzer, et al.
Journal of the American Chemical Society|August 22, 2017
Formation of Oxygen Radical Sites on MoVNbTeOx by Cooperative Electron RedistributionYuanyuan Zhu, Peter V Sushko, Daniel Melzer, et al.
Journal of Thoracic Disease|December 13, 2023
Osimertinib <i>vs.</i> afatinib as first-line treatment for patients with metastatic non-small cell lung cancer with an <i>EGFR</i> exon 19 deletion or exon 21 L858R mutationSophia Gilardone, Ram Thapa, José Laborde, et al.
Clinical Lung Cancer|January 16, 2026
Optimizing Tarlatamab Delivery in Small Cell and Neuroendocrine Lung Cancer: Real-World Insights into Step-Up Dosing and Prophylactic Tocilizumab UseUtsav Joshi, Faustine Ong, Daniel Melzer, et al.
Pageof 1